{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:30:38Z","timestamp":1793223038812,"version":"4.5.0"},"reference-count":133,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jaad.2020.07.105","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T11:58:00Z","timestamp":1596715080000},"page":"1667-1676","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Neurofibromatosis type 1: New developments in genetics and treatment"],"prefix":"10.1016","volume":"84","author":[{"given":"Britney N.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann M.","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc Zachary","family":"Handler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2020.07.105_bib1","first-page":"291","article-title":"Neurofibromatosis type 1","volume":"139","author":"Steen","year":"2004","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.jaad.2020.07.105_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10354-005-0185-1","volume":"155","author":"Wimmer","year":"2005","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/j.jaad.2020.07.105_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-4362.1980.tb01998.x","article-title":"Antique illustrations of neurofibromatosis","volume":"19","author":"Zanca","year":"1980","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2020.07.105_bib4","first-page":"575","article-title":"Neurofibromatosis. Conference statement. National Institutes of Health consensus development conference","volume":"45","year":"1988","journal-title":"Arch Neurol"},{"key":"10.1016\/j.jaad.2020.07.105_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/cncr.29738","article-title":"Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies","volume":"122","author":"Al-Rohil","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2020.07.105_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/jmg.2006.045906","article-title":"Guidelines for the diagnosis and management of individuals with neurofibromatosis 1","volume":"44","author":"Ferner","year":"2007","journal-title":"J Med Genet"},{"key":"10.1016\/j.jaad.2020.07.105_bib7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jpeds.2015.04.076","article-title":"Racial\/ethnic differences in pediatric brain tumor diagnoses in patients with neurofibromatosis type 1","volume":"167","author":"Abadin","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2020.07.105_bib8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/archdischild-2014-308084","article-title":"Annual review of children with neurofibromatosis type 1","volume":"101","author":"Dunning-Davies","year":"2015","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"10.1016\/j.jaad.2020.07.105_bib9","first-page":"923","volume":"10","author":"Karwacki","year":"2006","journal-title":"Med Wieku Rozwoj"},{"key":"10.1016\/j.jaad.2020.07.105_bib10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0092-8674(90)90252-A","article-title":"Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus","volume":"62","author":"Viskochil","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.jaad.2020.07.105_bib11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.2134734","article-title":"Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients","volume":"249","author":"Wallace","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.jaad.2020.07.105_bib12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0896-6273(92)90270-N","article-title":"The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytes","volume":"8","author":"Daston","year":"1992","journal-title":"Neuron"},{"key":"10.1016\/j.jaad.2020.07.105_bib13","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/jnc.13396","article-title":"A novel diagnostic method to detect truncated neurofibromin in Neurofibromatosis 1","volume":"135","author":"Esposito","year":"2015","journal-title":"J Neurochem"},{"key":"10.1016\/j.jaad.2020.07.105_bib14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nn792","article-title":"Neurofibromin regulates G protein-stimulated adenylyl cyclase activity","volume":"5","author":"Tong","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.jaad.2020.07.105_bib15","doi-asserted-by":"crossref","first-page":"9034","DOI":"10.1073\/pnas.1501032112","article-title":"In\u00a0vitro modeling of hyperpigmentation associated to neurofibromatosis type 1 using melanocytes derived from human embryonic stem cells","volume":"112","author":"Allouche","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2020.07.105_bib16","first-page":"297","article-title":"Neurofibromin in neurofibromatosis type 1 - mutations in NF1gene as a cause of disease","volume":"18","author":"Abramowicz","year":"2014","journal-title":"Dev Period Med"},{"key":"10.1016\/j.jaad.2020.07.105_bib17","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.3390\/ijms13021886","article-title":"The mTOR signalling pathway in human cancer","volume":"13","author":"Populo","year":"2012","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaad.2020.07.105_bib18","doi-asserted-by":"crossref","first-page":"e0141735","DOI":"10.1371\/journal.pone.0141735","article-title":"Functional analysis of mutations in exon 9 of NF1 reveals the presence of several elements regulating splicing","volume":"10","author":"Hernandez-Imaz","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2020.07.105_bib19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1086\/510781","article-title":"An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a clinically significant NF1 genotype-phenotype correlation","volume":"80","author":"Upadhyaya","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaad.2020.07.105_bib20","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/humu.10305","article-title":"Characterization of the somatic mutational spectrum of the neurofibromatosis type 1 (NF1) gene in neurofibromatosis patients with benign and malignant tumors","volume":"23","author":"Upadhyaya","year":"2004","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jaad.2020.07.105_bib21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s004390050746","article-title":"Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay","volume":"102","author":"Upadhyaya","year":"1998","journal-title":"Hum Genet"},{"key":"10.1016\/j.jaad.2020.07.105_bib22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ajmg.a.30346","article-title":"Intelligence in individuals with a neurofibromatosis type 1 microdeletion","volume":"131","author":"Descheemaeker","year":"2004","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jaad.2020.07.105_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/jmg.2003.014761","article-title":"Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2","volume":"41","author":"Venturin","year":"2004","journal-title":"J Med Genet"},{"key":"10.1016\/j.jaad.2020.07.105_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1479-7364-6-12","article-title":"Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?","volume":"6","author":"Alkindy","year":"2012","journal-title":"Hum Genomics"},{"key":"10.1016\/j.jaad.2020.07.105_bib25","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/jmg.28.11.752","article-title":"Watson syndrome: is it a subtype of type 1 neurofibromatosis?","volume":"28","author":"Allanson","year":"1991","journal-title":"J Med Genet"},{"key":"10.1016\/j.jaad.2020.07.105_bib26","first-page":"90","article-title":"Tandem duplication within a neurofibromatosis type 1 (NF1) gene exon in a family with features of Watson syndrome and Noonan syndrome","volume":"53","author":"Tassabehji","year":"1993","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaad.2020.07.105_bib27","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/hmg\/1.9.735","article-title":"Analysis of mutations at the neurofibromatosis 1 (NF1) locus","volume":"1","author":"Upadhyaya","year":"1992","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaad.2020.07.105_bib28","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/ng2113","article-title":"Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype","volume":"39","author":"Brems","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaad.2020.07.105_bib29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/jmg.2008.065474","article-title":"SPRED1 mutations (Legius syndrome): another clinically useful genotype for dissecting the neurofibromatosis type 1 phenotype","volume":"46","author":"Spurlock","year":"2009","journal-title":"J Med Genet"},{"key":"10.1016\/j.jaad.2020.07.105_bib30","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1136\/jmg.40.6.e82","article-title":"Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patients","volume":"40","author":"Ars","year":"2003","journal-title":"J Med Genet"},{"key":"10.1016\/j.jaad.2020.07.105_bib31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/jmg.2010.081760","article-title":"A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype-phenotype correlations","volume":"48","author":"Sharif","year":"2011","journal-title":"J Med Genet"},{"key":"10.1016\/j.jaad.2020.07.105_bib32","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/088307380201700804","article-title":"Genetics of neurofibromatosis 1 and the NF1 gene","volume":"17","author":"Viskochil","year":"2002","journal-title":"J Child Neurol"},{"key":"10.1016\/j.jaad.2020.07.105_bib33","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1212\/WNL.56.11.1433","article-title":"The clinical and diagnostic implications of mosaicism in the neurofibromatoses","volume":"56","author":"Ruggieri","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jaad.2020.07.105_bib34","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/humu.20389","article-title":"Comprehensive NF1 screening on cultured Schwann cells from neurofibromas","volume":"27","author":"Maertens","year":"2006","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jaad.2020.07.105_bib35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/01.icu.0000193070.32369.37","article-title":"Optic-nerve gliomas, chiasmal gliomas and neurofibromatosis type 1","volume":"17","author":"Sylvester","year":"2006","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.jaad.2020.07.105_bib36","first-page":"22","article-title":"Cafe-au-lait spots","volume":"66","author":"Cohen","year":"2000","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2020.07.105_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2008.12.051","article-title":"Neurofibromatosis type 1","volume":"61","author":"Boyd","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.07.105_bib38","first-page":"717","article-title":"The diagnosis of neurofibromatosis-1 in the child under the age of 6 years","volume":"143","author":"Obringer","year":"1989","journal-title":"Am J Dis Child"},{"issue":"Pt 6","key":"10.1016\/j.jaad.2020.07.105_bib39","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/111.6.1355","article-title":"Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales","volume":"111","author":"Huson","year":"1988","journal-title":"Brain"},{"key":"10.1016\/j.jaad.2020.07.105_bib40","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/sj.jid.5701095","article-title":"Somatic mutation analysis in NF1 cafe au lait spots reveals two NF1 hits in the melanocytes","volume":"128","author":"De Schepper","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2020.07.105_bib41","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1016\/j.jpag.2011.05.005","article-title":"A rare vulvar manifestation of neurofibromatosis 1 in a teen","volume":"24","author":"Skorupski","year":"2011","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"10.1016\/j.jaad.2020.07.105_bib42","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1159\/000327379","article-title":"Evolving pattern with age of cutaneous signs in neurofibromatosis type 1: a cross-sectional study of 728 patients","volume":"222","author":"Duong","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2020.07.105_bib43","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.ajpath.2010.12.056","article-title":"The pathoetiology of neurofibromatosis 1","volume":"178","author":"Jouhilahti","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaad.2020.07.105_bib44","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1093\/hmg\/ddz095","article-title":"Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation","volume":"28","author":"Rhodes","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaad.2020.07.105_bib45","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.39.5.311","article-title":"Malignant peripheral nerve sheath tumours in neurofibromatosis 1","volume":"39","author":"Evans","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.jaad.2020.07.105_bib46","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jaad.2015.05.021","article-title":"Dermoscopy of cutaneous neurofibromas associated with neurofibromatosis type 1","volume":"73","author":"Duman","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.07.105_bib47","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1023\/B:NEON.0000041891.39474.cb","article-title":"Peripheral nerve tumors: management strategies and molecular insights","volume":"69","author":"Bhattacharyya","year":"2004","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jaad.2020.07.105_bib48","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/00000478-199409000-00003","article-title":"Schwannoma (neurilemoma) with malignant transformation. A rare, distinctive peripheral nerve tumor","volume":"18","author":"Woodruff","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaad.2020.07.105_bib49","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6","article-title":"Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases","volume":"57","author":"Ducatman","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2020.07.105_bib50","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1634\/theoncologist.2013-0328","article-title":"Malignant peripheral nerve sheath tumors","volume":"19","author":"Farid","year":"2014","journal-title":"Oncologist"},{"key":"10.1016\/j.jaad.2020.07.105_bib51","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s13311-017-0518-y","article-title":"Cancer of the peripheral nerve in neurofibromatosis type 1","volume":"14","author":"Staedtke","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.jaad.2020.07.105_bib52","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1200\/JCO.2002.20.3.791","article-title":"Postoperative nomogram for 12-year sarcoma-specific death","volume":"20","author":"Kattan","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2020.07.105_bib53","first-page":"180","article-title":"[Blue-red macules and pseudoatrophic macules in neurofibromatosis 1]","volume":"129","author":"Zeller","year":"2002","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2020.07.105_bib54","first-page":"100","article-title":"Pseudoatrophic macules: a variant of neurofibroma","volume":"57","author":"Pique","year":"1996","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2020.07.105_bib55","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1136\/jmg.39.8.e45","article-title":"Multifocal glomus tumours of the fingers in two patients with neurofibromatosis type 1","volume":"39","author":"De Smet","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.jaad.2020.07.105_bib56","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/archderm.1996.03890350134028","article-title":"Juvenile xanthogranuloma, neurofibromatosis 1, and juvenile chronic myeloid leukemia","volume":"132","author":"Gutmann","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2020.07.105_bib57","first-page":"745","article-title":"Nevus anemicus associated with neurofibromatosis type 1 in a neonate: a case report","volume":"150","author":"Cerini","year":"2015","journal-title":"G Ital Dermatol Venereol"},{"key":"10.1016\/j.jaad.2020.07.105_bib58","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/pde.12525","article-title":"Nevus anemicus: a distinctive cutaneous finding in neurofibromatosis type 1","volume":"32","author":"Hernandez-Martin","year":"2015","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2020.07.105_bib59","first-page":"465","article-title":"An update on neurofibromatosis type 1: not just cafe-au-lait spots and freckling. Part II. Other skin manifestations characteristic of NF1. NF1 and cancer","volume":"107","author":"Hernandez-Martin","year":"2016","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.jaad.2020.07.105_bib60","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00008390-200404000-00014","article-title":"Cutaneous malignant melanoma and neurofibromatosis type 1","volume":"14","author":"Guillot","year":"2004","journal-title":"Melanoma Res"},{"key":"10.1016\/j.jaad.2020.07.105_bib61","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/neuonc\/nou235","article-title":"Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a neurofibromatosis Clinical Trials Consortium phase II study","volume":"17","author":"Weiss","year":"2015","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jaad.2020.07.105_bib62","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.18632\/oncotarget.2194","article-title":"The NF1 gene revisited\u2014from bench to bedside","volume":"5","author":"Yap","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaad.2020.07.105_bib63","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/08830738030180070401","article-title":"Optic pathway gliomas in children with and without neurofibromatosis 1","volume":"18","author":"Czyzyk","year":"2003","journal-title":"J Child Neurol"},{"key":"10.1016\/j.jaad.2020.07.105_bib64","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jaapos.2015.06.003","article-title":"Strabismus in patients with neurofibromatosis type 1-associated optic pathway glioma","volume":"19","author":"Parness-Yossifon","year":"2015","journal-title":"J AAPOS"},{"key":"10.1016\/j.jaad.2020.07.105_bib65","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1212\/01.wnl.0000179303.72345.ce","article-title":"The nature and frequency of cognitive deficits in children with neurofibromatosis type 1","volume":"65","author":"Hyman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jaad.2020.07.105_bib66","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/jnnp.2009.179630","article-title":"Brain structure and function in neurofibromatosis type 1: current concepts and future directions","volume":"81","author":"Payne","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jaad.2020.07.105_bib67","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s11689-015-9128-3","article-title":"Cerebral volumetric abnormalities in neurofibromatosis type 1: associations with parent ratings of social and attention problems, executive dysfunction, and autistic mannerisms","volume":"7","author":"Huijbregts","year":"2015","journal-title":"J Neurodev Disord"},{"key":"10.1016\/j.jaad.2020.07.105_bib68","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1469-8749.2002.tb00780.x","article-title":"Treatment of ADHD in neurofibromatosis type 1","volume":"44","author":"Mautner","year":"2002","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jaad.2020.07.105_bib69","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/jmg.2009.075937","article-title":"Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions","volume":"47","author":"Mautner","year":"2010","journal-title":"J Med Genet"},{"key":"10.1016\/j.jaad.2020.07.105_bib70","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jpeds.2015.06.031","article-title":"Unraveling gene interactions in patients with neurofibromatosis type 1","volume":"167","author":"Pletcher","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2020.07.105_bib71","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1159\/000440956","article-title":"Reversible growth hormone excess in two girls with neurofibromatosis type 1 and optic pathway glioma","volume":"84","author":"Bruzzi","year":"2015","journal-title":"Horm Res Paediatr"},{"issue":"Suppl 2","key":"10.1016\/j.jaad.2020.07.105_bib72","first-page":"289","article-title":"Growth and pubertal disorders in neurofibromatosis type 1","volume":"16","author":"Virdis","year":"2003","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.jaad.2020.07.105_bib73","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/B978-0-444-62702-5.00004-4","article-title":"Neurofibromatosis type 1","volume":"132","author":"Anderson","year":"2015","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.jaad.2020.07.105_bib74","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/pbc.25812","article-title":"Congenital retroperitoneal teratoma in neurofibromatosis type 1","volume":"63","author":"Yap","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jaad.2020.07.105_bib75","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/bjc.1994.431","article-title":"Neurofibromatosis and childhood leukaemia\/lymphoma: a population-based UKCCSG study","volume":"70","author":"Stiller","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jaad.2020.07.105_bib76","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/01.pas.0000176433.81079.bd","article-title":"Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinicopathologic and molecular genetic study of 45 cases","volume":"30","author":"Miettinen","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jaad.2020.07.105_bib77","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jpeds.2004.02.026","article-title":"Neurofibromatosis in children with rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma Study IV","volume":"144","author":"Sung","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.jaad.2020.07.105_bib78","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bone.2008.10.050","article-title":"Congenital pseudarthrosis of neurofibromatosis type 1: impaired osteoblast differentiation and function and altered NF1 gene expression","volume":"44","author":"Leskela","year":"2009","journal-title":"Bone"},{"key":"10.1016\/j.jaad.2020.07.105_bib79","first-page":"1","article-title":"Neurofibromatosis in children","volume":"218","author":"Crawford","year":"1986","journal-title":"Acta Orthop Scand Suppl"},{"key":"10.1016\/j.jaad.2020.07.105_bib80","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00003086-200208000-00013","article-title":"Orthopaedic manifestations of neurofibromatosis in children: an update","author":"Vitale","year":"2002","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.jaad.2020.07.105_bib81","doi-asserted-by":"crossref","first-page":"228","DOI":"10.5435\/00124635-200804000-00006","article-title":"Congenital pseudarthrosis of the Tibia","volume":"16","author":"Vander Have","year":"2008","journal-title":"J Am Acad Orthop Surg"},{"key":"10.1016\/j.jaad.2020.07.105_bib82","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13023-019-1196-0","article-title":"Identification and characterization of NF1 and non-NF1 congenital pseudarthrosis of the tibia based on germline NF1 variants: genetic and clinical analysis of 75 patients","volume":"14","author":"Zhu","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jaad.2020.07.105_bib83","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00431-016-2757-z","article-title":"Prevalence of neurofibromatosis type 1 in congenital pseudarthrosis of the tibia","volume":"175","author":"Van Royen","year":"2016","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jaad.2020.07.105_bib84","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nm.3583","article-title":"Asfotase-alpha improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1","volume":"20","author":"de la Croix Ndong","year":"2014","journal-title":"Nat Med"},{"key":"10.1016\/j.jaad.2020.07.105_bib85","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cmet.2006.10.010","article-title":"ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae","volume":"4","author":"Elefteriou","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.jaad.2020.07.105_bib86","doi-asserted-by":"crossref","first-page":"39695","DOI":"10.18632\/oncotarget.13932","article-title":"Novel phenotypes of NF1 patients from unrelated Chinese families with tibial pseudarthrosis and anemia","volume":"8","author":"Banerjee","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jaad.2020.07.105_bib87","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13052-018-0483-z","article-title":"Clinical and molecular characterization of 112 single-center patients with neurofibromatosis type 1","volume":"44","author":"Corsello","year":"2018","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.jaad.2020.07.105_bib88","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.4238\/2012.July.10.6","article-title":"A novel NF1 mutation in a Chinese patient with giant cafe-au-lait macule in neurofibromatosis type 1 associated with a malignant peripheral nerve sheath tumor and bone abnormality","volume":"11","author":"Tong","year":"2012","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.jaad.2020.07.105_bib89","doi-asserted-by":"crossref","first-page":"402","DOI":"10.11607\/ofph.1787","article-title":"Neurofibromatosis type 1 accompanied by craniofacial pain: literature review and descriptive case","volume":"31","author":"Son","year":"2017","journal-title":"J Oral Facial Pain Headache"},{"key":"10.1016\/j.jaad.2020.07.105_bib90","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.1167\/iovs.14-16053","article-title":"In\u00a0vivo detection of choroidal abnormalities related to NF1: feasibility and comparison with standard NIH diagnostic criteria in pediatric patients","volume":"56","author":"Parrozzani","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jaad.2020.07.105_bib91","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/cne.20689","article-title":"Forebrain substrates of reward and motivation","volume":"493","author":"Wise","year":"2005","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.jaad.2020.07.105_bib92","doi-asserted-by":"crossref","first-page":"69r","DOI":"10.1203\/PDR.0b013e318212b40f","article-title":"Neurobiology of attention deficit\/hyperactivity disorder","volume":"69","author":"Purper-Ouakil","year":"2011","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jaad.2020.07.105_bib93","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1093\/hmg\/ddq382","article-title":"Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice","volume":"19","author":"Brown","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaad.2020.07.105_bib94","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ana.23793","article-title":"Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice","volume":"73","author":"Diggs-Andrews","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaad.2020.07.105_bib95","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1093\/hmg\/ddv103","article-title":"Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning","volume":"24","author":"Anastasaki","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.jaad.2020.07.105_bib96","doi-asserted-by":"crossref","first-page":"e48983","DOI":"10.7554\/eLife.48983","article-title":"Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1","volume":"8","author":"Robinson","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.jaad.2020.07.105_bib97","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1542\/peds.90.6.924","article-title":"Diagnostic outcome in children with multiple cafe au lait spots","volume":"90","author":"Korf","year":"1992","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2020.07.105_bib98","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.ebiom.2016.04.005","article-title":"Comprehensive RNA analysis of the NF1 gene in classically affected NF1","volume":"7","author":"Evans","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jaad.2020.07.105_bib99","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/ajmg.a.20211","article-title":"Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome","volume":"122a","author":"King","year":"2003","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jaad.2020.07.105_bib100","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1136\/jmg.26.11.712","article-title":"A genetic study of von Recklinghausen neurofibromatosis in south east Wales. II. Guidelines for genetic counselling","volume":"26","author":"Huson","year":"1989","journal-title":"J Med Genet"},{"key":"10.1016\/j.jaad.2020.07.105_bib101","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1086\/519562","article-title":"Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1","volume":"81","author":"Maertens","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaad.2020.07.105_bib102","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/1098-1004(200006)15:6<541::AID-HUMU6>3.0.CO;2-N","article-title":"Exhaustive mutation analysis of the NF1 gene allows identification of 95% of mutations and reveals a high frequency of unusual splicing defects","volume":"15","author":"Messiaen","year":"2000","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jaad.2020.07.105_bib103","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/jmg.2008.065243","article-title":"SPRED1 germline mutations caused a neurofibromatosis type 1 overlapping phenotype","volume":"46","author":"Pasmant","year":"2009","journal-title":"J Med Genet"},{"key":"10.1016\/j.jaad.2020.07.105_bib104","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(12)61023-X","article-title":"Noonan syndrome","volume":"381","author":"Roberts","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2020.07.105_bib105","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1086\/498454","article-title":"NF1 gene mutations represent the major molecular event underlying neurofibromatosis-Noonan syndrome","volume":"77","author":"De Luca","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaad.2020.07.105_bib106","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/B978-0-444-52902-2.00045-X","article-title":"The surgery of peripheral nerves (including tumors)","volume":"115","author":"Fugleholm","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.jaad.2020.07.105_bib107","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1055\/s-0034-1396793","article-title":"Massive plexiform neurofibroma of the neck and larynx","volume":"19","author":"Mobashir","year":"2015","journal-title":"Int Arch Otorhinolaryngol"},{"key":"10.1016\/j.jaad.2020.07.105_bib108","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s13555-012-0007-5","article-title":"Carbon dioxide laser treatment of cutaneous neurofibromas","volume":"2","author":"Chiang","year":"2012","journal-title":"Dermatol Ther (Heidelb)"},{"key":"10.1016\/j.jaad.2020.07.105_bib109","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1046\/j.1365-2133.2001.04214.x","article-title":"Carbon dioxide laser for removal of multiple cutaneous neurofibromas","volume":"144","author":"Moreno","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.07.105_bib110","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/00000637-199106000-00016","article-title":"Use of the carbon dioxide laser in treating multiple cutaneous neurofibromas","volume":"26","author":"Becker","year":"1991","journal-title":"Ann Plast Surg"},{"key":"10.1016\/j.jaad.2020.07.105_bib111","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5999\/aps.2013.40.1.57","article-title":"Radiofrequency ablation and excision of multiple cutaneous lesions in neurofibromatosis type 1","volume":"40","author":"Kim","year":"2013","journal-title":"Arch Plast Surg"},{"key":"10.1016\/j.jaad.2020.07.105_bib112","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1097\/01.prs.0000204863.40195.dd","article-title":"Radiofrequency in the treatment of craniofacial plexiform neurofibromatosis: a pilot study","volume":"117","author":"Baujat","year":"2006","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jaad.2020.07.105_bib113","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.mcna.2019.07.004","article-title":"The diagnosis and management of neurofibromatosis type 1","volume":"103","author":"Ly","year":"2019","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jaad.2020.07.105_bib114","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1158\/1535-7163.MCT-19-0319","article-title":"The novel glutamine antagonist prodrug JHU395 has antitumor activity in malignant peripheral nerve sheath tumor","volume":"19","author":"Lemberg","year":"2020","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jaad.2020.07.105_bib115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1177\/0883073817739509","article-title":"Optic pathway gliomas in neurofibromatosis type 1","volume":"33","author":"Campen","year":"2018","journal-title":"J Child Neurol"},{"key":"10.1016\/j.jaad.2020.07.105_bib116","doi-asserted-by":"crossref","first-page":"e1792","DOI":"10.1542\/peds.2013-1224","article-title":"Sirolimus improves pain in NF1 patients with severe plexiform neurofibromas","volume":"133","author":"Hua","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaad.2020.07.105_bib117","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5483\/BMBRep.2009.42.5.239","article-title":"Adult hippocampal neurogenesis and related neurotrophic factors","volume":"42","author":"Lee","year":"2009","journal-title":"BMB Rep"},{"key":"10.1016\/j.jaad.2020.07.105_bib118","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/neuonc\/nou004","article-title":"Phase 2 randomized, flexible crossover, double-blinded, placebo-controlled trial of the farnesyltransferase inhibitor tipifarnib in children and young adults with neurofibromatosis type 1 and progressive plexiform neurofibromas","volume":"16","author":"Widemann","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.jaad.2020.07.105_bib119","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.pediatrneurol.2007.01.009","article-title":"Phase I trial of pirfenidone in children with neurofibromatosis 1 and plexiform neurofibromas","volume":"36","author":"Babovic-Vuksanovic","year":"2007","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.jaad.2020.07.105_bib120","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1212\/WNL.0b013e318207b031","article-title":"Phase I trial of pegylated interferon-alpha-2b in young patients with plexiform neurofibromas","volume":"76","author":"Jakacki","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jaad.2020.07.105_bib121","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S1470-2045(12)70414-X","article-title":"Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial","volume":"13","author":"Robertson","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaad.2020.07.105_bib122","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.cell.2008.08.041","article-title":"Nf1-dependent tumors require a microenvironment containing Nf1+\/\u2013 and c-kit-dependent bone marrow","volume":"135","author":"Yang","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jaad.2020.07.105_bib123","doi-asserted-by":"crossref","first-page":"e107760","DOI":"10.1371\/journal.pone.0107760","article-title":"Nilotinib is more potent than imatinib for treating plexiform neurofibroma in\u00a0vitro and in\u00a0vivo","volume":"9","author":"Wei","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2020.07.105_bib124","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1242\/jcs.013912","article-title":"Neurofibromin as a regulator of melanocyte development and differentiation","volume":"121","author":"Diwakar","year":"2008","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jaad.2020.07.105_bib125","first-page":"202","article-title":"Vitamin D3 analogues improve cafe au lait spots in patients with von Recklinghausen's disease: experimental and clinical studies","volume":"9","author":"Nakayama","year":"1999","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2020.07.105_bib126","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1346-8138.2007.00258.x","article-title":"Treatment of pigmented lesions of neurofibromatosis 1 with intense pulsed-radio frequency in combination with topical application of vitamin D3 ointment","volume":"34","author":"Yoshida","year":"2007","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2020.07.105_bib127","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/1346-8138.12256","article-title":"Narrowband ultraviolet B irradiation increases the serum level of vitamin D(3) in patients with neurofibromatosis 1","volume":"40","author":"Nakayama","year":"2013","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2020.07.105_bib128","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1002\/humu.22392","article-title":"NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience","volume":"34","author":"Sabbagh","year":"2013","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jaad.2020.07.105_bib129","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jmoldx.2010.09.002","article-title":"A highly sensitive genetic protocol to detect NF1 mutations","volume":"13","author":"Valero","year":"2011","journal-title":"J Mol Diagn"},{"key":"10.1016\/j.jaad.2020.07.105_bib130","doi-asserted-by":"crossref","first-page":"E1506","DOI":"10.1002\/humu.21271","article-title":"NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype","volume":"31","author":"Pasmant","year":"2010","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jaad.2020.07.105_bib131","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/cge.12187","article-title":"A clinical and genetic overview of 18 years neurofibromatosis type 1 molecular diagnostics in the Netherlands","volume":"85","author":"van Minkelen","year":"2014","journal-title":"Clin Genet"},{"key":"10.1016\/j.jaad.2020.07.105_bib132","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10689-006-9001-3","article-title":"Molecular diagnosis of neurofibromatosis type 1: 2 years experience","volume":"6","author":"Griffiths","year":"2007","journal-title":"Fam Cancer"},{"key":"10.1016\/j.jaad.2020.07.105_bib133","first-page":"43","article-title":"Neurofibromatosis type 1 (von Recklinghausen disease): a case report and review of the literature","volume":"47","author":"Pozharashka","year":"2020","journal-title":"Acta Med Bulg"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220323070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220323070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:58:03Z","timestamp":1759273083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962220323070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":133,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0190962220323070"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.07.105","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neurofibromatosis type 1: New developments in genetics and treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.07.105","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}